Biofluid quantification of TWEAK/Fn14 axis in combination with a selected biomarker panel improves assessment of prostate cancer aggressiveness

Biofluid quantification of TWEAK/Fn14 axis in combination with a selected biomarker panel improves assessment of prostate cancer aggressiveness

Abstract Background Conventional clinical biomarkers cannot accurately differentiate indolent from aggressive prostate cancer (PCa). We investigated the usefulness of a biomarker panel measured exclusively in biofluids for assessment of PCa aggressiveness. Methods We collected biofluid samples (plas...

Полное описание

Библиографические подробности
Главные авторы: Xavier Ruiz-Plazas, Esther Rodríguez-Gallego, Marta Alves, Antonio Altuna-Coy, Javier Lozano-Bartolomé, Manel Portero-Otin, Joan Francesc García-Fontgivell, Salomé Martínez-González, José Segarra, Matilde R. Chacón
Формат: Статья
Язык:English
Опубликовано: BMC 2019-09-01
Серии:Journal of Translational Medicine
Предметы:
TWEAK/Fn14 axis
Prostate cancer
Biomarkers
Diagnosis
Biofluids
Online-ссылка:http://link.springer.com/article/10.1186/s12967-019-2053-6

Internet

http://link.springer.com/article/10.1186/s12967-019-2053-6

Схожие документы